PreveCeutical Medical (PRVCF) Financial Statements
PreveCeutical Medical Financial Overview
PreveCeutical Medical's market cap is currently $9.13M. The company's EPS TTM is $-0.00; its P/E ratio is -16.67; PreveCeutical Medical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Mar 24 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -14.43K | $ -10.10K | $ -9.86K | $ -9.89K | $ -5.09K |
| Operating Income | $ -3.37M | $ -812.47K | $ -963.12K | $ -1.10M | $ -897.85K |
| EBITDA | $ -1.35M | $ -837.46K | $ -955.09K | $ -1.23M | $ -829.83K |
| Net Income | $ -1.58M | $ -1.17K | $ -1.27M | $ -1.48M | $ -1.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.24K | $ 59.14K | $ 1.43K | $ 5.62K | $ 16.06K |
| Total Assets | $ 1.45M | $ 225.66K | $ 181.51K | $ 189.14K | $ 161.20K |
| Total Debt | $ 4.68M | $ 4.46M | $ 3.89M | $ 3.23M | $ 2.93M |
| Net Debt | $ 4.67M | $ 4.40M | $ 3.89M | $ 3.23M | $ 2.91M |
| Total Liabilities | $ 7.69M | $ 6.86M | $ 5.96M | $ 4.82M | $ 4.27M |
| Stockholders' Equity | $ -6.24M | $ -6.64M | $ -5.78M | $ -4.64M | $ -4.10M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.72M | $ -428.49K | $ -296.97K | $ -222.64K | $ -481.59K |
| Operating Cash Flow | $ -1.72M | $ -426.69K | $ -296.97K | $ -222.64K | $ -426.39K |
| Investing Cash Flow | $ -2.96K | $ -1.80K | $ 0.00 | $ 850.00 | $ -52.70K |
| Financing Cash Flow | $ 1.68M | $ 487.64K | $ 293.62K | $ 211.72K | $ 136.75K |
Currency in CAD
